UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor

Xenobiotica, 2010-06, Vol.40 (6), p.369-380

2010

Volltextzugriff (PDF)

Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile

MedChemComm, 2017-04, Vol.8 (4), p.771-779

2017

Volltextzugriff (PDF)

P.16.18 OPTIMIZED CONTRAST-ENHANCED ULTRASONOGRAPHY FOR CHARACTERIZATION OF FOCAL LIVER LESIONS IN CIRRHOSIS: A SINGLE-CENTER RETROSPECTIVE STUDY

Digestive and liver disease, 2014-03, Vol.46, p.S120-S120

2014

Volltextzugriff (PDF)

P.10.14 CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN THE EVALUATION OF PANCREATIC MASSES COMPARED WITH HISTOLOGY OF ULTRASOUND (US)-GUIDED PERCUTANEOUS BIOPSY

Digestive and liver disease, 2013-03, Vol.45, p.S162-S163

2013

Volltextzugriff (PDF)

P.18.13 EARLY WASH-OUT (<60 SECONDS) AT CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN LIVER NODULES IN CIRRHOSIS IS HIGHLY SUGGESTIVE FOR NON-HEPATOCELLULAR CARCINOMA (HCC) MALIGNANCY

Digestive and liver disease, 2013-03, Vol.45, p.S214-S214

2013

Volltextzugriff (PDF)

P.13.17 ULTRASOUND-GUIDED PERCUTANEOUS BIOPSY FOR THE DIAGNOSIS OF GASTROINTESTINAL MASSES

Digestive and liver disease, 2013-03, Vol.45, p.S186-S187

2013

Volltextzugriff (PDF)

T.03.5 EFFECT OF ENVIRONMENTAL BISPHENOL A EXPOSURE ON TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION

Digestive and liver disease, 2023-03, Vol.55, p.S146-S147

2023

Volltextzugriff (PDF)

From “MAFLD” to “MASLD”: was this revolution worth it? A head-to-head real-life comparison of MAFLD and MASLD criteria in estimating liver disease worsening risk in lean and not-lean steatotic patients

Digestive and liver disease, 2024-09, Vol.56, p.S326-S327

2024

Volltextzugriff (PDF)

Multidisciplinary management combining hepatologist counseling, cognitive/behavioral therapy, and nutritional support significantly improves clinical outcomes of Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) patients

Digestive and liver disease, 2024-09, Vol.56, p.S318-S319

2024

Volltextzugriff (PDF)

Spleen area affects the predictive performance for decompensation of the platelet count-based non-invasive tools in MASLD-related cirrhosis: a preliminary observation

Digestive and liver disease, 2024-09, Vol.56, p.S323-S323

2024

Volltextzugriff (PDF)

OC.11.2: RED CELL DISTRIBUTION WIDTH (RDW) TO PLATELET RATIO (RDW/PLT RATIO) ACCURATELY PREDICTS 7-YEAR DECOMPENSATION AND MODALITIES OF DISEASE PROGRESSION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE: A PRELIMINARY OBSERVATION [THE REPLAY STUDY]

Digestive and liver disease, 2024-04, Vol.56, p.S183-S184

2024

Volltextzugriff (PDF)

P.1.6: CONTRAST ENHANCED ULTRASOUND (CEUS) IN THE CHARACTERIZATION OF FOCAL LESIONS IN BRIGHT LIVER OF ONCOLOGY PATIENTS

Digestive and liver disease, 2011, Vol.43, p.S149-S150

2011

Volltextzugriff (PDF)

Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake

Drug metabolism and disposition, 2016-10, Vol.44 (10), p.1633-1642

2016

Volltextzugriff (PDF)

The treatment of NAFLD

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.299

2005

Volltextzugriff (PDF)

Invasive Constrictive Pericarditis

Journal of cardiovascular magnetic resonance, 2024, Vol.26, p.100942, Article 100942

2024

Volltextzugriff (PDF)

Ultrasound-guided percutaneous biopsy for the diagnosis of gastrointestinal masses

Ultraschall in der Medizin, 2013-10, Vol.34 (S 01)

2013

Volltextzugriff (PDF)

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Future oncology (London, England), 2013-02, Vol.9 (2), p.283-294

2013

Volltextzugriff (PDF)

Nutritional Aspects in Non Alcoholic Fatty Liver Disease (NAFLD)

Journal of nutritional ecology and food research, 2016-03, Vol.3 (1), p.75-80

2016

Volltextzugriff (PDF)

Contrast-enhanced ultrasonography (CEUS) in the evaluation of pancreatic masses compared with histology of ultrasound (US)-guided percutaneous biopsy

Ultraschall in der Medizin, 2013, Vol.34 (S 01)

2013

Volltextzugriff (PDF)

Early wash-out (< 60 seconds) at contrast-enhanced ultrasonography in liver nodules in cirrhosis is highly suggestive for non-hepatocellular carcinoma malignancy

Ultraschall in der Medizin, 2013, Vol.34 (S 01)

2013

Volltextzugriff (PDF)

Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease

Digestive and liver disease, 2006-04, Vol.38, p.S31-S31

2006

Volltextzugriff (PDF)

Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study

Minerva gastroenterologica e dietologica, 2005-06, Vol.51 (2), p.193

2005

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study

Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor

Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile

P.16.18 OPTIMIZED CONTRAST-ENHANCED ULTRASONOGRAPHY FOR CHARACTERIZATION OF FOCAL LIVER LESIONS IN CIRRHOSIS: A SINGLE-CENTER RETROSPECTIVE STUDY

P.10.14 CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN THE EVALUATION OF PANCREATIC MASSES COMPARED WITH HISTOLOGY OF ULTRASOUND (US)-GUIDED PERCUTANEOUS BIOPSY

P.18.13 EARLY WASH-OUT (<60 SECONDS) AT CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN LIVER NODULES IN CIRRHOSIS IS HIGHLY SUGGESTIVE FOR NON-HEPATOCELLULAR CARCINOMA (HCC) MALIGNANCY

P.13.17 ULTRASOUND-GUIDED PERCUTANEOUS BIOPSY FOR THE DIAGNOSIS OF GASTROINTESTINAL MASSES

T.03.5 EFFECT OF ENVIRONMENTAL BISPHENOL A EXPOSURE ON TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION

From “MAFLD” to “MASLD”: was this revolution worth it? A head-to-head real-life comparison of MAFLD and MASLD criteria in estimating liver disease worsening risk in lean and not-lean steatotic patients

Multidisciplinary management combining hepatologist counseling, cognitive/behavioral therapy, and nutritional support significantly improves clinical outcomes of Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) patients

Spleen area affects the predictive performance for decompensation of the platelet count-based non-invasive tools in MASLD-related cirrhosis: a preliminary observation

OC.11.2: RED CELL DISTRIBUTION WIDTH (RDW) TO PLATELET RATIO (RDW/PLT RATIO) ACCURATELY PREDICTS 7-YEAR DECOMPENSATION AND MODALITIES OF DISEASE PROGRESSION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE: A PRELIMINARY OBSERVATION [THE REPLAY STUDY]

P.1.6: CONTRAST ENHANCED ULTRASOUND (CEUS) IN THE CHARACTERIZATION OF FOCAL LESIONS IN BRIGHT LIVER OF ONCOLOGY PATIENTS

Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake

The treatment of NAFLD

Invasive Constrictive Pericarditis

Ultrasound-guided percutaneous biopsy for the diagnosis of gastrointestinal masses

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Nutritional Aspects in Non Alcoholic Fatty Liver Disease (NAFLD)

Contrast-enhanced ultrasonography (CEUS) in the evaluation of pancreatic masses compared with histology of ultrasound (US)-guided percutaneous biopsy

Early wash-out (< 60 seconds) at contrast-enhanced ultrasonography in liver nodules in cirrhosis is highly suggestive for non-hepatocellular carcinoma malignancy

Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease

Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study

Suchergebnisse filtern